Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: fishin2 who wrote (1345)	7/23/1998 11:15:00 PM
From: Double E	Read Replies (1) \| Respond to of 4140

To All - Believe me, the new PR firm is busy making plans for SNRS. They will have a carefully planned strategy to take advantage of the "problems" we all know exist with the "VISX procedure" for treating hyperopia. The PR firm has a limited hand to play with at this time because of the stage SNRS is in for the FDA approval process. They realize the "powerhouse" nature of this company and of this "product" SNRS has to sell. They will be well prepared when the time comes and that is when IMHO we will see the dramatic results in company growth and stock price appreciation. I am prepared to wait because I think it will be well worth it! Double E